FONAR Corp Files 10-Q for Q3 FY2025
Ticker: FONR · Form: 10-Q · Filed: May 15, 2025 · CIK: 355019
Sentiment: neutral
Topics: 10-Q, earnings, medical-devices
TL;DR
**FONAR 10-Q FILED: Q3 FY25 RESULTS ARE IN.**
AI Summary
FONAR Corp filed its 10-Q for the quarter ended March 31, 2025, reporting on its financial performance. The company, based in Melville, NY, operates in the electromedical and electrotherapeutic apparatus industry. This filing provides an update on its financial position and operational results for the third quarter of fiscal year 2025.
Why It Matters
This 10-Q filing provides investors and analysts with the latest financial data for FONAR Corp, crucial for understanding the company's performance and making informed investment decisions.
Risk Assessment
Risk Level: medium — As a publicly traded company in the medical device sector, FONAR Corp faces inherent market, regulatory, and competitive risks detailed in its SEC filings.
Key Numbers
- Q3 2025 — Fiscal Quarter (Reporting period for the 10-Q filing)
- 0630 — Fiscal Year End (Indicates the end of FONAR's fiscal year)
Key Players & Entities
- FONAR CORP (company) — Filer of the 10-Q
- Melville, NY (location) — Company's business address
- March 31, 2025 (date) — End of the reporting period
- 20250331 (date) — Conformed period of report
- 0000355019 (company) — Central Index Key for FONAR CORP
FAQ
What is the primary business of FONAR Corp?
FONAR Corp is involved in the electromedical & electrotherapeutic apparatus industry, as indicated by its SIC code [3845].
What period does this 10-Q filing cover?
This 10-Q filing covers the quarter ended March 31, 2025.
Where is FONAR Corp located?
FONAR Corp's business and mailing address is 110 Marcus Drive, Melville, NY 11747.
What is the SEC file number for FONAR Corp?
The SEC file number for FONAR Corp is 000-10248.
When was this 10-Q filing submitted?
This 10-Q filing was filed as of May 15, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding FONAR CORP (FONR).